Biodesix, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Services » Medical Or Nursing Services
NVTAInvitae Corp. 0.90%49.801.4%$134.51m
GHGuardant Health, Inc. 0.98%120.830.0%$128.48m
DVADaVita, Inc. -1.22%107.043.5%$96.17m
SDCSmileDirectClub, Inc. 1.68%12.140.0%$89.94m
FLGTFulgent Genetics, Inc. -3.00%45.670.7%$78.29m
ONEM1Life Healthcare, Inc. 1.26%35.260.0%$70.40m
NTRANatera, Inc. 0.21%90.951.2%$57.29m
MDMEDNAX, Inc. -0.29%20.9611.1%$46.31m
CHEChemed Corp. 0.04%476.8710.1%$43.18m
AMEDAmedisys, Inc. -1.00%244.9611.3%$37.91m
LHCGLHC Group, Inc. 0.02%196.172.9%$37.02m
NEONeoGenomics, Inc. 0.52%47.505.7%$28.83m
OTRKOntrak, Inc. 1.79%52.250.0%$24.30m
ACHCAcadia Healthcare Co., Inc. -0.10%42.2427.1%$23.31m
CRDFCardiff Oncology, Inc. -1.48%21.990.0%$19.19m

Company Profile

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. It offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer; and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It is a data-driven diagnostic solutions company with proprietary AI platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The firm offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. . The company was founded in 2005 and is headquartered in Boulder, CO.